Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of PERIoperative Factor Xa Inhibitor Discontinuation in Patients With Atrial Fibrillation Who Undergoing Minor Bleeding Risk Elective Procedure or Surgery: A Prospective, Multicenter, Noninterventional Study (PERIXa Study)

NCT05801068 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05801068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05801068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of PERIoperative Factor Xa Inhibitor Discontinuation in Patients With Atrial Fibrillation Who Undergoing Minor Bleeding Risk Elective Procedure or Surgery: A Prospective, Multicenter, Noninterventional Study (PERIXa Study)
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2020
Completion date
May 15, 2024
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, atrial fibrillation